Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2713 (LINC02713)

Target
LINC02713
Molecular classification
Other, Long non-coding RNA, long intergenic non-coding RNA, lincRNA
01

Overview

Long intergenic non-protein coding RNA 2713 (LINC02713) is classified as a **long intergenic non-coding RNA (lincRNA)**, a subclass of long non-coding RNAs (lncRNAs) defined as RNA transcripts longer than 200 nucleotides that do not overlap with known protein-coding genes[1][3]. The general class of lincRNAs can participate in fine-tuning the expression of neighboring genes, chromatin remodeling, genome architecture modification, and transcriptional regulation, frequently exhibiting tissue-specific effects[1][3]. However, there is **no evidence in the literature to date that LINC02713 has a characterized molecular function, disease association, or drug interaction**. It is not considered a protein, enzyme, receptor, transporter, nor a currently recognized therapeutic target. No widely used abbreviation, alias, or alternate name was found other than the systematic designation "LINC02713". The search did not yield any biomarker relevance, mechanism of action, or safety profile for this molecule. Note: - There is **no indication this gene is misspelled**, but its characterization in biomedical research is extremely limited or unreported; this could signify a lack of importance as a therapeutic target or a lack of study. - LINC01133, found in one result, is a different lincRNA and should not be conflated with LINC02713[2]. - Most available functional information pertains to the broader lincRNA category, not to LINC02713 specifically[1][3].

02

Biological functions

Unknown
03

Disease associations

Unknown

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2713 (LINC02713).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2713 (LINC02713).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call